title: [Ofloxacin and ciprofloxacin in the treatment of sexually-transmitted diseases].
abstract: A complex clinico-laboratory++ examination and treatment were made of 76 women with inflammatory processes in the urogenital tract. Gonorrhea, trichomoniasis, chlamydiosis and Ureaplasma infection were detected in 60, 31.4, 41 and 14 per cent of the cases, respectively. There were affections of the rectum by gonococci, chlamydia, ureaplasmas and Trichomonas in 55, 32, 10.6 and 6.6 per cent of the cases, respectively. The frequency of chlamydia in the oropharynx amounted to 30 per cent whereas gonococci and ureaplasma were less frequent i.e. 9 and 1.2 per cent, respectively. The combination of the above pathogens in the rectum were the following: gonococci and chlamydia (15 per cent of the cases), gonococci, chlamydia and Trichomonas (7.3 per cent), gonococci and ureaplasma (7.3 per cent), ureaplasma and chlamydia (7.8 per cent). In the throat the association of gonococci and chlamydia was detected in 3.7 per cent of the cases. It should be indicated that the signs of sex-transmitted diseases were few, which required careful clinico-laboratory examination of the extragenital foci in the patients with inflammatory urogenital diseases. Ofloxacin showed a high efficacy in the treatment of patients with gonorrhea and ureaplasmosis. Its use in treatment of chlamydiosis proved inexpedient while ciprofloxacin was effective in the treatment of the infection.
authors.forename: V N
authors.initials: VN
authors.lastname: Bednova
authors.forename: L A
authors.initials: LA
authors.lastname: Bakalova
authors.forename: A V
authors.initials: AV
authors.lastname: Bugrov
authors.forename: T I
authors.initials: TI
authors.lastname: Navolotskaia
authors.forename: V I
authors.initials: VI
authors.lastname: Kisina
authors.forename: T E
authors.initials: TE
authors.lastname: Vakhnina
mesh_terms: D002690:Chlamydia Infections / Q000188:drug therapy* / Q000209:etiology / Q000635:transmission; D002939:Ciprofloxacin / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy* / Q000209:etiology / Q000635:transmission; D006801:Humans; D015242:Ofloxacin / Q000008:administration & dosage*; D011349:Proctitis / Q000188:drug therapy* / Q000209:etiology; D012749:Sexually Transmitted Diseases / Q000188:drug therapy*; D014245:Trichomonas Infections / Q000188:drug therapy* / Q000209:etiology / Q000635:transmission; D016869:Ureaplasma Infections / Q000188:drug therapy* / Q000209:etiology / Q000635:transmission; D014526:Urethritis / Q000188:drug therapy* / Q000209:etiology
chemical_list: D002939:Ciprofloxacin; D015242:Ofloxacin
vernacular_title: Ofloksatsin i tsiprofloksatsin v terapii infektsiĭ, peredavaemykh polovym putem.